D

Dyadic International
D

DYAI

0.98990
USD
-0.10
(-9.18%)
مغلق
حجم التداول
20
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
29,786,745
أصول ذات صلة
A
APPS
-0.06500
(-1.47%)
4.35500 USD
C
CRBP
-0.15000
(-1.99%)
7.40000 USD
G
GLMD
-0.04000
(-2.84%)
1.37000 USD
K
KNSA
0.965
(3.72%)
26.935 USD
O
OGEN
-0.00070
(-0.36%)
0.19120 USD
T
TXG
-0.37000
(-4.33%)
8.17000 USD
V
VNRX
0.00040
(0.08%)
0.51540 USD
V
VSTM
0.83500
(11.16%)
8.31500 USD
المزيد
الأخبار المقالات

العنوان: Dyadic International

القطاع: Healthcare
الصناعة: Biotechnology
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.